Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Chirurg ; 88(4): 311-316, 2017 Apr.
Article in German | MEDLINE | ID: mdl-28083600

ABSTRACT

BACKGROUND: Lymphatic fistulas and lymphoceles are known complications after vascular surgery of the groin and after extended surgical interventions in the pelvic region. Unfortunately, conservative standard therapies are not always successful. OBJECTIVES: Evaluation of the therapeutic efficacy and related side effects of percutaneous low-dose irradiation in patients with lymphorrhea and definition of its importance. MATERIAL AND METHODS: Current presentation of previously published case series, reviews and guidelines. RESULTS: The use of low-dose irradiation therapy with single doses of 0.3-0.5 Gy leads to a cessation of the lymphatic flow in a high percentage of patients when standard therapies do not show a sufficient effect. With cessation of lymphorrhea irradiation should be terminated. Acute side effects have not been reported and the risk of tumor induction is almost negligible. CONCLUSION: Low-dose irradiation is an effective and very well-tolerated therapeutic alternative in the treatment of lymphatic fistulas and lymphorrhea when conservative therapies are unsuccessful.


Subject(s)
Fistula/radiotherapy , Lymph Node Excision , Lymphatic Diseases/radiotherapy , Lymphatic Irradiation/methods , Postoperative Complications/radiotherapy , Cone-Beam Computed Tomography/methods , Dose Fractionation, Radiation , Female , Humans , Inguinal Canal , Lymphocele/radiotherapy , Male , Practice Guidelines as Topic , Radiotherapy Dosage , Radiotherapy, Computer-Assisted/methods , Radiotherapy, Intensity-Modulated/methods , Treatment Outcome
2.
Clin Genitourin Cancer ; 13(4): e223-e228, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25497586

ABSTRACT

INTRODUCTION: The purpose of the study was to evaluate the feasibility of irradiation after prostatectomy in the presence of asymptomatic pelvic lymphocele. PATIENTS AND METHODS: The inclusion criteria for this study were: (1) patients referred for postoperative (adjuvant or salvage) intensity modulated radiotherapy (IMRT; 66-69 Gy in 30 fractions); (2) detection of postoperative pelvic lymphocele at the simulation computed tomography [CT] scan; (3) no clinical symptoms; and (4) written informed consent. Radiotherapy toxicity and occurrence of symptoms or complications of lymphocele were analyzed. Dosimetric data (IMRT plans) and the modification of lymphocele volume during radiotherapy (cone beam CT [CBCT] scan) were evaluated. RESULTS: Between January 2011 and July 2013, in 30 of 308 patients (10%) treated with radiotherapy after prostatectomy, pelvic lymphocele was detected on the simulation CT. The median lymphocele volume was 47 cm(3) (range, 6-467.3 cm(3)). Lymphocele was not included in planning target volume (PTV) in 8 cases (27%). Maximum dose to lymphocele was 57 Gy (range, 5.7-73.3 Gy). Radiotherapy was well tolerated. In all but 2 patients, lymphoceles remained asymptomatic. Lymphocele drainage-because of symptom occurrence-had to be performed in 2 patients during IMRT and in one patient, 7 weeks after IMRT. CBCT at the end of IMRT showed reduction in lymphocele volume and position compared with the initial data (median reduction of 37%), more pronounced in lymphoceles included in PTV. CONCLUSION: Radiotherapy after prostatectomy in the presence of pelvic asymptomatic lymphocele is feasible with acceptable acute and late toxicity. The volume of lymphoceles decreased during radiotherapy and this phenomenon might require intermediate radiotherapy plan evaluation.


Subject(s)
Lymphocele/radiotherapy , Pelvis/pathology , Prostatic Neoplasms/pathology , Prostatic Neoplasms/radiotherapy , Aged , Dose Fractionation, Radiation , Humans , Lymphocele/pathology , Male , Middle Aged , Pelvis/radiation effects , Postoperative Care , Prostatic Neoplasms/surgery , Radiotherapy, Intensity-Modulated/adverse effects , Radiotherapy, Intensity-Modulated/methods , Tomography, X-Ray Computed , Treatment Outcome
3.
Laryngoscope ; 123(5): 1184-9, 2013 May.
Article in English | MEDLINE | ID: mdl-23532713

ABSTRACT

OBJECTIVES/HYPOTHESIS: To report the long-term outcomes of radiation therapy (RT), and the impact of fractionation size and RT duration on HIV patients with Benign Lymphoepithelial Cysts (BLEC) of the parotid glands. METHODS: From January 2000 to 2011, 30 patients were eligible for our single institution retrospective study. Both parotids were treated with 24 Gy via RT. The median age at RT, HIV diagnosis, and duration of HIV seropositive was 45 years (28-64), 38 years (23-53), and 11 years (6-35), respectively. Patients were stratified into two groups. Group A and B received 2Gyx12 and 1.5Gyx16, respectively. RESULTS: After a median follow-up of 66 months (12-141), the overall response (OvR) was 93% of the patients. Specifically, complete response (CR) and partial response (PR) were 80% and 13%, respectively. In group A, 100% had CR. Treatment failure was 7% and all were in group B, which was mainly due to poor compliance. A Chi-square test showed significant relationship between OvR and RT duration (P <0.001), and a positive trend between CR and fraction size of 2 Gy (P = 0.053). All acute toxicities were grade ≤ 2, specifically mucositis (48%), xerostomia (45%), skin erythema (41%), and altered taste (14%). Two patients (6.7%) experienced long-term grade 1 xerostomia. CONCLUSION: RT provides a sustained long-term cosmetic control for BLEC of the parotid glands in HIV patients. Failures are uncommon, and the late side effects have been negligible.


Subject(s)
HIV Infections/complications , Lymphocele/radiotherapy , Parotid Diseases/radiotherapy , Adult , Dose-Response Relationship, Drug , Female , Follow-Up Studies , Humans , Lymphocele/complications , Lymphocele/diagnosis , Male , Middle Aged , Parotid Diseases/complications , Parotid Diseases/diagnosis , Radiation Dosage , Retrospective Studies , Time Factors , Tomography, X-Ray Computed , Treatment Outcome
4.
Strahlenther Onkol ; 176(1): 9-15, 2000 Jan.
Article in German | MEDLINE | ID: mdl-10650830

ABSTRACT

BACKGROUND: The treatment of persistent postoperative lymphatic fistulas or lymphoceles is often a problem. Approximately 2% of patients will develop lymphatic fistula after vascular surgery. This can require a long lasting conservative therapy. If spontaneous cure fails, a second operation with wound revision becomes necessary. We studied low-dose percutaneous radiotherapy to be used as an alternative treatment in addition to conservative or surgical therapy. PATIENTS AND METHODS: Between 1989 and 1998 29 patients (25 with lymphatic fistulas, 4 with lymphoceles) received radiation therapy. Depending on the depth of the fistula 27 patients were treated with electrons (7 to 18 MeV). Two other patients suffering of retroperitoneal lymphoceles received a treatment with photons (15 MV). In all patients the fractionation was 4- to 5 x 1.0 Gy/week and the dose ranged from 3 to 12 Gy depending upon the onset of the radiation therapy effect. RESULTS: In 27 of 28 evaluable patients a complete disappearance of the fistula or lymphocele was achieved by radiation during therapy or shortly afterwards. In 1 case no benefit was observed after a dose of 11 Gy. This patient required further surgery with wound exploration. CONCLUSION: Low dose percutaneous radiotherapy (up to 10 to 12 Gy) is effective to heal lymphatic fistulas and lymphoceles without complications. Individual dosage is required because doses even lower than 10 Gy may be effective. Radiation can be effective even after a failed conservative therapy or instead of surgery.


Subject(s)
Fistula/radiotherapy , Lymphatic Diseases/radiotherapy , Lymphocele/radiotherapy , Adult , Aged , Aged, 80 and over , Coronary Artery Bypass/adverse effects , Electrons/therapeutic use , Female , Fistula/etiology , Humans , Lymphatic Diseases/etiology , Lymphocele/etiology , Male , Middle Aged , Photons/therapeutic use , Postoperative Complications/radiotherapy , Radiotherapy, High-Energy , Retrospective Studies , Vascular Surgical Procedures/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL
...